Functional restoration of disease-associated VDR-CH variants through heterodimeric partner RXR and VDR ligand calcitriol partnership
Cellular Signalling · 2027-02 · 150 · 112987
DOI: 10.1016/j.cellsig.2026.112987 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2027-02. Verfasst von Neha Kumari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi 110067, India. Die Arbeit nennt 68 Literaturangaben. Gefördert von: India Ministry of Science & Technology Department of Biotechnology.
Abstract (Originalsprache)
The vitamin D receptor (VDR), a ligand-activated nuclear receptor, plays essential roles in calcium metabolism, immune function, and gene regulation through its heterodimerization with retinoid X receptor (RXR). Mutations in the ligand-binding domain (LBD) of VDR have been implicated in hereditary vitamin D-resistant rickets and type 1 diabetes, yet the molecular and cellular basis of their dysfunction remains poorly understood. Here, we functionally characterize compound heterozygous (CH) variants of VDR harboring SNP L263R and R391S, which are located in a conserved region of the LBD. These variants exhibited i) aberrant subcellular localization, ii) markedly reduced transcriptional activity, and iii) failure in associating with the mitotic chromatin. Notably, neither RXR co-expression nor calcitriol treatment alone restored receptor function. However, it was interesting to observe that the formation of a ternary complex of VDR-CH variants (L263R or R391S), along with heterodimeric partner RXR and VDR ligand calcitriol, promoted nuclear translocation and mitotic chromatin interaction, but the transcriptional rescue was mutation-dependent, with stronger recovery for R391S and limited recovery for L263R. The interaction of these three components, i.e., VDR variant, RXR, and calcitriol, together appeared to contribute to structural and functional stabilization of receptor conformation. This study reveals how specific VDR LBD mutations disrupt receptor architecture and cellular dynamics at multiple levels. The ability of RXR and calcitriol together to restore key functional properties suggests that conformational rescue of VDR-CH variant can be possibly achieved through co-ordinated heterodimerization and ligand treatments. The findings here offer important mechanistic insight into VDR-RXR-calcitriol interactions, suggesting hitherto unexplored therapeutic avenues through conformational rescue of disease-inflicting structurally disordered receptor.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi 110067, India.
- Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi 110067, India. Electronic address: rktyagi@yahoo.com.
Förderung
- India Ministry of Science & Technology Department of Biotechnology
Zitieren
APA
Kumari, N., Tripathi, A., Kumar, S., & Tyagi, R. K. (2027). Functional restoration of disease-associated VDR-CH variants through heterodimeric partner RXR and VDR ligand calcitriol partnership. Cellular Signalling, 150, 112987. https://doi.org/10.1016/j.cellsig.2026.112987
Vancouver
Kumari N, Tripathi A, Kumar S, Tyagi RK. Functional restoration of disease-associated VDR-CH variants through heterodimeric partner RXR and VDR ligand calcitriol partnership. Cellular Signalling. 2027;150:112987. doi:10.1016/j.cellsig.2026.112987
BibTeX
@article{Kumari2027,
author = {Kumari, Neha and Tripathi, Anjali and Kumar, Sudhir and Tyagi, Rakesh K},
title = {Functional restoration of disease-associated VDR-CH variants through heterodimeric partner RXR and VDR ligand calcitriol partnership},
journal = {Cellular Signalling},
year = {2027},
volume = {150},
pages = {112987},
doi = {10.1016/j.cellsig.2026.112987}
}
EUVIMED